We found that miR-9-3p was significantly elevated in both Gem-treated MCF7 and HCC1806 cells (P < 0.001, Supplementary Fig. S4B, C), suggesting that it might be involved in the inhibition of cancer cell growth and migration under Gem treatment. The gene discussed is GEM; the disease is cancer.